Current Research Interests
Dr. Ostrovnaya is focused on developing and applying statistical methods in cancer genomics. One of her research projects involves methodology for distinguishing second primary tumors from metastases using mutational profiles. Other interests include developing new methods for investigating tumor heterogeneity and prognostic modeling using high throughput molecular data. Dr. Ostrovnaya is a biostatistician for the head and neck, translational kidney and bladder cancer oncology groups.
Visit PubMed for a full listing of Irina Ostrovnaya’s journal articles
Pubmed is an online index of biomedical articles maintained by the U.S. National Library of Medicine and the National Institutes of Health.My Downloads
Disclosures
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Irina Ostrovnaya discloses the following relationships and financial interests:
-
Ataraxis
Professional Services and Activities
The information published here is a complement to other publicly reported data and is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2023 through disclosure submission in spring 2024). This data reflects interests that may or may not still exist. This data is updated annually.
Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].
View all disclosures